Clinical Trial Detail

NCT ID NCT02042378
Title A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

pancreatic ductal adenocarcinoma

Therapies

Rucaparib

Age Groups: adult

No variant requirements are available.